ASX - By Stock
|
OSL |
Re:
OncoSil advancements in Pancreatic Cancer Treatment
|
|
EquityAngel
|
13 |
2.9K |
0 |
02/12/23 |
02/12/23 |
ASX - By Stock
|
13
|
2.9K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
OncoSil advancements in Pancreatic Cancer Treatment
|
|
EquityAngel
|
13 |
2.9K |
0 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
13
|
2.9K
|
0
|
|
ASX - By Stock
|
OSL |
OncoSil advancements in Pancreatic Cancer Treatment
|
|
EquityAngel
|
13 |
2.9K |
0 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
13
|
2.9K
|
0
|
|
ASX - By Stock
|
LRS |
Re:
Ann: Colina High Grade Results
|
|
EquityAngel
|
61 |
28K |
1 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
61
|
28K
|
1
|
|
ASX - By Stock
|
DRE |
Re:
Ann: Large, High Confidence Yin Ironstone Resource - Mangaroon
|
|
EquityAngel
|
33 |
18K |
4 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
33
|
18K
|
4
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen receives $4.8 million R&D tax incentive rebate
|
|
EquityAngel
|
10 |
4.1K |
4 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
10
|
4.1K
|
4
|
|
IPOs
|
FSE |
Re:
IPO - Fuse Minerals Limited - 18 December 2023 #
|
|
EquityAngel
|
11 |
9.6K |
2 |
01/12/23 |
01/12/23 |
IPOs
|
11
|
9.6K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
OncoSil FDA designation & PanCO study success
|
|
EquityAngel
|
6 |
1.9K |
1 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
6
|
1.9K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
OncoSil AMG Resolutions
|
|
EquityAngel
|
5 |
1.2K |
4 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
5
|
1.2K
|
4
|
|
ASX - By Stock
|
OSL |
Re:
OncoSil Medical AGM on 29th of November 2023
|
|
EquityAngel
|
3 |
1.2K |
3 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
3
|
1.2K
|
3
|
|
IPOs
|
FSE |
Re:
IPO - Fuse Minerals Limited - 18 December 2023 #
|
|
EquityAngel
|
11 |
9.6K |
0 |
21/11/23 |
21/11/23 |
IPOs
|
11
|
9.6K
|
0
|
|